Tb. Rajavashisth et al., Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques - Evidence for activation by proinflammatory mediators, CIRCULATION, 99(24), 1999, pp. 3103-3109
Citations number
32
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Background-Matrix metalloproteinases (MMPs) are expressed in atheroscleroti
c plaques, where in their active form, they may contribute to vascular remo
deling and plaque disruption. In this study, we tested the hypothesis that
membrane type 1 MMP (MT1-MMP), a novel transmembrane MMP that activates pro
-MMP-2 (gelatinase A), is expressed in human atherosclerotic plaques and th
at its expression is regulated by proinflammatory molecules.
Methods and Results--MT1-MMP expression was examined in normal and atherosc
lerotic human arteries by immunocytochemistry with specific antibodies. MT1
-MMP expression in human saphenous vein-derived smooth muscle cells (SMCs)
maintained in tissue culture was determined under basal conditions and in r
esponse to proinflammatory molecules (interleukin [IL]-1 alpha, tumor necro
sis factor [TNF]-alpha, and oxidized LDL [ox-LDL]) by use of Northern blot
and ribonuclease protection assays for mRNA, Western blot and immunoprecipi
tation for protein, and gelatin zymography for catalytic activity. Medial S
MCs of normal vessel wall expressed MT1-MMP, In atherosclerotic arteries, M
T1-MMP expression was noted within the complex atheroma colocalizing with S
MCs and macrophages (M phi). Cultured SMCs constitutively expressed MT1-MMP
mRNA and protein, which increased 2- to 4-fold over control in a time-depe
ndent manner within 4 to 8 hours of exposure to IL-1 alpha, TNF-alpha, and
ox-LDL (thiobarbituric acid-reactive substances, 13.4 nmol/mg LDL protein),
whereas native LDL had no effect. Flow cytometry revealed MT1-MMP expressi
on by human monocyte-derived M phi, which increased 3.8-fold over baseline
within 6 hours after exposure to 10 ng/mL TNF-alpha.
Conclusions-This study demonstrates that MT1-MMP, an activator of pro-MMP-2
, is expressed by SMCs and M phi in human atherosclerotic plaques. Furtherm
ore, proinflammatory molecules upregulate MT1-MMP expression in vascular SM
Cs and M phi. Thus, activation of SMCs and M phi by proinflammatory molecul
es may influence extracellular matrix remodeling in atherosclerosis by regu
lating MT1-MMP expression.